Literature DB >> 3081629

B cell sensitivity to natural killing: correlation with target cell stage of differentiation and state of activation.

W J Storkus, J R Dawson.   

Abstract

When 13 B cell lines were phenotyped with a panel of B cell, stage-specific monoclonal antibodies and ordered with respect to differentiation state; their sensitivity to natural killer (NK) cell-mediated conjugate formation and cytolysis was found to be stage dependent. Target cell lines expressing an early B cell phenotype (B1+B2-CALLA+DU-ALL1 +/-) or an intermediate phenotype (B1+B2+CALLA-DU-ALL1+) were NK resistant. Late phenotypic B cells (B1+B2-CALLA-DU-ALL1-) were highly susceptible to NK cytolysis. Individual B cell lines when induced with sodium butyrate or retinoic acid expressed altered B cell phenotype and NK susceptibility. For example, SB, an intermediate B cell line and initially NK resistant, when induced to express a later B cell phenotype became NK sensitive. BJA.B, a late B cell line and initially NK sensitive, when induced to differentiate lost most of its sensitivity to natural killing. Since loss of the B2 antigen is associated with B cell activation, we further phenotyped the B cell lines and induced B cell lines with the 4F2 and 5E9 (anti-transferrin receptor) monoclonal reagents. All cell lines tested expressed each of these antigens, but with varying intensities. While the intensity of 4F2 expression appeared to correlate well with NK sensitivity on both resting and differentiated B cell lines, the intensity of 5E9 expression did not. Peripheral blood B cells express a similar pattern of reactivity to natural killing when stimulated with pokeweed mitogen (PWM) in vitro. B cell sensitivity to NK-mediated events peaked at day 4 of incubation and correlated with the loss of the B2 antigen and acquisition of the 4F2 and 5E9 antigens; sensitivity to natural killing was diminished in the presence of the PCA-1 antigen. The expression of the NK-susceptible phenotype among B cells appears to be differentiation stage- and activation state-dependent. It is during this period of ontogeny that the NK cell may cytolytically regulate the B cell transition to a plasma cell.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3081629

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

2.  Normal mitogen-induced suppression of the interleukin-6 (IL-6) response and its deficiency in systemic lupus erythematosus.

Authors:  R J Warrington; W J Rutherford
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

Review 3.  NK cells and their ability to modulate T cells during virus infections.

Authors:  Kevin D Cook; Stephen N Waggoner; Jason K Whitmire
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

Review 4.  The role of iron and iron binding proteins in lymphocyte physiology and pathology.

Authors:  J D Kemp
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

Review 5.  Natural Killer Cell Regulation of B Cell Responses in the Context of Viral Infection.

Authors:  Ivayla E Gyurova; Ayad Ali; Stephen N Waggoner
Journal:  Viral Immunol       Date:  2019-12-03       Impact factor: 2.257

6.  NK cells inhibit humoral immunity by reducing the abundance of CD4+ T follicular helper cells during a chronic virus infection.

Authors:  Kevin D Cook; Hannah C Kline; Jason K Whitmire
Journal:  J Leukoc Biol       Date:  2015-05-18       Impact factor: 4.962

7.  Differential killing of pre-B acute lymphoblastic leukaemia cells by activated NK cells and the NK-92 ci cell line.

Authors:  G S D Reid; S Bharya; H-G Klingemann; K R Schultz
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

8.  Cytotoxic and immunoregulatory function of intestinal lymphocytes in Chlamydia trachomatis proctitis of nonhuman primates.

Authors:  S P James; A S Graeff; M Zeitz; E Kappus; T C Quinn
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  Unfractionated spleen cells but not natural killer (NK) cells from RFM donors prevent the progression of host-versus-graft disease in murine RFM/(T6 x RFM)F1 chimeras.

Authors:  R C Hard; M R Patel; L M Keller; T J Linna
Journal:  Immunology       Date:  1988-03       Impact factor: 7.397

10.  Elimination in vivo of developing T cells by natural killer cells.

Authors:  Eckart Schott; Roberto Bonasio; Hidde L Ploegh
Journal:  J Exp Med       Date:  2003-10-20       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.